Afisi Ismaila

机构：GlaxoSmithKline (United States), Impact, McMaster University · ORCID：0000-0002-2876-8308

发表论文 215 篇 · 总被引 7644 次 · h-index 28

代表论文

Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study (2024 · International Journal of COPD · 被引 18)
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study (2023 · International Journal of COPD · 被引 12)
Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study (2024 · BMJ Open · 被引 10)
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study (2024 · BMJ Open Respiratory Research · 被引 8)
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK (2023 · International Journal of COPD · 被引 6)
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians (2024 · Respiratory Research · 被引 3)